FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-137034.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-137034v1
24/1/49    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Zhao-Shea, R.
Right arrow Articles by Tapper, A. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao-Shea, R.
Right arrow Articles by Tapper, A. R.
(The FASEB Journal. 2010;24:49-57.)
© 2010 FASEB

Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism

Rubing Zhao-Shea*, Bruce N. Cohen{dagger}, Herwig Just{dagger}, Tristan McClure-Begley{ddagger}, Paul Whiteaker§, Sharon R. Grady{ddagger}, Outi Salminen||, Paul D. Gardner*, Henry A. Lester{dagger} and Andrew R. Tapper*,1

* Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, USA;

{dagger} Division of Biology, California Institute of Technology, Pasadena, California, USA;

{ddagger} Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA;

§ Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA; and

|| Department of Pharmacy, Division of Pharmacology and Toxicology, University of Helsinki, Helsinki, Finland

1 Correspondence: University of Massachusetts Medical School, Brudnick Neuropsychiatric Research Institute, 303 Belmont St., Worcester, MA 01604. E-mail: andrew.tapper{at}umassmed.edu

Recent studies suggest that high-affinity neuronal nicotinic acetylcholine receptors (nAChRs) containing {alpha}4 and β2 subunits ({alpha}4β2*) functionally interact with G-protein-coupled dopamine (DA) D2 receptors in basal ganglia. We hypothesized that if a functional interaction between these receptors exists, then mice expressing an M2 point mutation (Leu9'Ala) rendering {alpha}4 nAChRs hypersensitive to ACh may exhibit altered sensitivity to a D2-receptor agonist. When challenged with the D2R agonist, quinpirole (0.5–10 mg/kg), Leu9'Ala mice, but not wild-type (WT) littermates, developed severe, reversible motor impairment characterized by rigidity, catalepsy, akinesia, and tremor. While striatal DA tissue content, baseline release, and quinpirole-induced DA depletion did not differ between Leu9'Ala and WT mice, quinpirole dramatically increased activity of cholinergic striatal interneurons only in mutant animals, as measured by increased c-Fos expression in choline acetyltransferase (ChAT)-positive interneurons. Highlighting the importance of the cholinergic system in this mouse model, inhibiting the effects of ACh by blocking muscarinic receptors, or by selectively activating hypersensitive nAChRs with nicotine, rescued motor symptoms. This novel mouse model mimics the imbalance between striatal DA/ACh function associated with severe motor impairment in disorders such as Parkinson’s disease, and the data suggest that a D2R–{alpha}4*-nAChR functional interaction regulates cholinergic interneuron activity.—Zhao-Shea, R., Cohen, B. N., Just, H., McClure-Begley, T., Whiteaker, P., Grady, S. R., Salminen, O., Gardner, P. D., Lester, H. A., Tapper, A. R. Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism.


Key Words: acetylcholine • striatum • nicotine • parkinsonian • interneuron







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by The Federation of American Societies for Experimental Biology.